According toMedical Xpress,The new research by the Mass General Brightam health system (USA) shows that the use of aspirin can help reduce the risk of colorectal cancer in people with many risk factors.
Aspirin has the potential to reduce the risk of developing colorectal cancer in people with many risk factors - Photo: Medical Xpress
"We seek to identify individuals who are more likely to benefit from aspirin to facilitate more personalized prevention strategies," said Dr. Andrew Chan, co -author of senior author from Mass Cancer Center.General and colorectal cancer center in young people of Massachusetts General Hospital (USA), said.
The authors analyzed the health data of more than 107,000 Americans, collected by a national survey.
They compare the rectal cancer rate in aspirin users regularly to those who do not use aspirin regularly.
Regular use of aspirin is defined as 2 or more standard doses (325 mg) per week or low -dose aspirin (81 mg) daily.
These people use this medication often prescribed by a doctor to treat another health problem.
Over 10 years of monitoring, the incidence of colorectal cancer accumulated in people who regularly use aspirin is 33% lower than non -non -use people.
This benefit increases by 40% for those who have the most unhealthy lifestyle factors, which is the highest risk of developing cancer.
In contrast, the benefits are not much in the healthiest people, simply because this group has reduced the risk of cancer development by themselves despite other risk factors, so the incidence of the disease is also low.
Previous studies have found evidence that aspirin can reduce protein production that causes prostaglandin inflammation, which can promote cancer growth.
Aspirin can also block signal transmission pathway that causes cells to develop in addition to control, affecting immune reactions against cancer cells and preventing the growth of blood vessels providing nutrients for nutrients toCancer cells.
Thus, the results have just been published in the Journal of MedicineJama oncologyIt shows that aspirin has great potential in reducing the risk of colorectal cancer development in high -risk subjects.
Of course, more tests will be needed to find the right regimen to achieve the highest efficiency as well as reduce the risk of side effects of Aspirin, which is most commonly gastric ulcer.
Patients also need a doctor's prescription when using this drug for cancer -related purposes.
According to global statistics published by the World Health Organization (WHO) in early 2024, colorectal cancer is the third type of cancer in terms of common level (after lung and breast cancer) and second rows.Two the number of deaths (only after lung cancer).
Sat Aug 03 2024 10:03:29 GMT+0700 (GI ờ Đ(Gi ờ Đ; d ư ơ ng)